Clinical trial Recruiting at 2 sites Interventional Ages 18 to 60

Comparing Botulinum Toxin A and Steroids for Heel Pain Treatment

Official title: Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis: a Randomized Controlled Study

Run by Insel Gruppe AG, University Hospital Bern · NCT02196155 · Data updated 2026-11-12

This study is testing whether Botulinum Toxin A injections can help people with chronic heel pain feel better compared to cortisone injections.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment54 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations2 sites (Bern and 1 other locations)
StatusRecruiting
StartedJuly 2016
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedDecember 10, 2024
Trial IDNCT02196155 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals experiencing chronic plantar fasciitis symptoms for more than three months who have not responded to previous treatments.

Probably not a fit

Patients with active differential diagnoses, recent injections or surgeries for plantar fasciitis, or certain medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of Botulinum Toxin A (BTX-A) injections compared to cortisone injections for treating chronic plantar fasciitis, a common cause of heel pain. The study aims to address the lack of consensus on the best non-operative treatment for this condition by evaluating whether BTX-A can provide better outcomes by targeting the underlying muscle tightness rather than just alleviating symptoms. Participants will receive either BTX-A, cortisone, or saline injections, and their progress will be monitored over time to assess pain relief and functional improvement.

Why it matters

Potential benefit: If successful, this treatment could provide a more effective and safer option for patients suffering from chronic plantar fasciitis.

How similar studies have gone: While there is limited evidence comparing BTX-A to cortisone for plantar fasciitis, similar approaches using BTX-A for other musculoskeletal conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical symptoms of a plantar fasciitis
* Plantar fasciitis in MRI
* Exclusion of differential diagnoses
* Symptoms more than 3 months
* Absolution of 3 months unsuccessful treatment
* Written informed consent

Exclusion Criteria

* Active differential diagnoses
* Contraindications: pregnancy and breastfeeding, infection at injection sites, allergy against BTX-A
* Previous injections or surgery for plantar fasciitis
* Neurological diseases affecting the peripheral nervous system

Where it's running

  • Dep, of Orthopaedic Surgery, Inselspital, University of Berne
    Bern, Switzerland
    Recruiting
  • Department of Orthopaedic Surgery, Kantonsspital Lucerne
    Lucerne, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Fabian Krause, PD Dr. — Dep. of Orthopaedic Surgery, Inselspital, University of Berne, Freiburgstrasse, 3010 Berne, Switzerland
  • Study coordinator: Fabian Krause, PD Dr.
  • Email: fabian.krause@insel.ch
  • Phone: 0041316322220

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.